In May 2018, the FDA released a report titled "FDA Report on the Quality, Safety and Effectiveness of Servicing of Medical Devices," issued by the Secretary of Health and Human Services and in accordance with The Food and Drug Administration Reauthorization Act (FDARA). The FDA examined product servicing by manufacturers, healthcare establishments and third-party providers who refurbish, recondition, rebuild, remarket, service and repair medical devices.
Topics: Industry Advancements, Industry Trends, San Diego, CA, ISO Certification, Quality Management System, Medical Device Field Action, Medical Device Industry, Med-Tech Industry Update, Field Technical
The importance of providing and fearlessly seeking feedback at Novasyte goes back to the Company's inception in 2008. This cultural priority is not simply a theory discussed at the annual company meeting, but a living, breathing, organically-developed reality of the day-to-day environment that allows for cross-departmental synergies to develop, relationships to grow, and issues to be resolved in real-time.
The award recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities. Gleeson was selected by an independent panel of judges, and the award was presented at a special gala event at the Fairmont Grand Del Mar on June 7.
On April 30, 2018, the California Supreme Court unanimously ruled to establish clearer distinctions between W-2 employees and 1099 independent contractors. Additionally, they made the process more difficult for employers to classify an employee as an independent contractor through an updated, more restrictive "ABC" test.
Novasyte is pleased to announce we have earned a finalist ranking on the San Diego Business Journal's Fastest Growing Private Companies 2018 list for the fourth consecutive year.
This annual list is compiled by the San Diego Business Journal and is determined on the basis of rapid expansion. Novasyte placed on the list of 100 highlighted organizations for sustaining a three-year growth rate of 70 percent. This growth can be attributed to the work our expanding corporate and field teams perform to support a number of the largest, global device, diagnostic and drug manufacturers.
The awards program recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities. Gleeson was selected as a finalist by a panel of independent judges. Award winners will be announced at a special gala event on June 7, 2018 at the Fairmont Grand Del Mar.
Tim has been placed on an exclusive shortlist of San Diego-based CEOs who show exceptional leadership in their work and hold admiration from their respective teams.
Novasyte is excited to announce that Tim Gleeson, Chairman and CEO, has been selected as a semi-finalist in the Ernst & Young Entrepreneur Of The Year 2018 San Diego Regional Awards program.
Novasyte is thrilled to announce the appointment of Todd Schaefer to Senior Vice President of Sales and Marketing. Todd officially joined Novasyte on Monday, April 9, 2018 and is the first to hold this position.
He will be responsible for managing the sales, marketing, pharma and recall departments within Novasyte. Additionally, he will be a part of Senior Leadership Team and will contribute to the development and execution of Novasyte’s strategic goals.
Novasyte has announced the creation and appointment of two corporate positions. Ryan Jones, formerly VP of Sales, now holds the title of VP of Pharma Services and Hillary Medina, formerly Senior Director of Recall Services, now acts as VP of Field and Recall Services. Both positions were effective on Monday, April 9, 2018.